Research Articles | Page 19 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Apr 2024 Haematologica Aplastic Anemia
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Detectable mutations precede late myeloid neoplasia in aplastic anemia Feb 2021 Haematologica Aplastic Anemia
Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions May 2020 Haematologica Aplastic Anemia
Long term survivors in severe aplastic anemia: standard mortality rates now comparable to controls? Jul 2023 Haematologica Aplastic Anemia
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Jun 2023 Haematologica Aplastic Anemia
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Aug 2024 Haematologica Aplastic Anemia
Myelodysplastic Syndromes: Moving Towards Personalized Management May 2020 Haematologica Myelodysplastic Syndromes (MDS)
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial Nov 2024 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Granulocyte transfusions in severe aplastic anemia Jun 2024 Haematologica Aplastic Anemia